Weight-Loss Drug Zepbound Is Being Tested as a Treatment for Long Covid

Weight-Loss Drug Zepbound Is Being Tested as a Treatment for Long Covid thumbnail

GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties can help alleviate symptoms of long Covid.

LEAVE A REPLY

Your email address will not be published. Required fields are marked *